Tests for Antiphospholipid syndrome (APS)

  1. ๐Ÿ“š Citations
  2. ๐Ÿฆ  Taxons (Bacteria) report by studies
  3. ๐Ÿฅฃ Candidates for improving (avoids and takes)
  4. ๐Ÿ”ฎ Bacteria Related Conditions
  5. es-xenogene is located in Spain and is expensive compared to others

Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.

  1. Biomesight and BiomeSightRdp ships worldwide - including the US
  2. Thryve is now Ombre Labs but only ships to the US
  3. CosmosId is available thru NirvanaBiome
  4. Medivere is based in Germany
  5. American Gut
  6. Xenogene is both the most expensive and most detail for rare bacteria. They are based in Spain
  7. uBiome is no longer in business
The Percentage of significant bacteria each test reports on
Name Percentage
Thorne 81.8%
FASTQ processed thru both Thryve and BiomeSight 81.8%
BiomeSight 77.3%
CerbaLab 77.3%
Thryve 68.2%
es-xenogene 63.6%
uBiome 59.1%
CosmosId 54.5%
bugspeak 54.5%
SequentiaBiotech 45.5%
Medivere 45.5%
BiomeSightRdp 45.5%
AmericanGut 36.4%
Microba 36.4%
Laboratorio Teletest 36.4%
Gut Zoomer (vibrant-wellness) 27.3%
Diagnostic Solution GI-Map (cfu/gm) 27.3%
Genova Gi Effects (cfu/g) 27.3%
Nordic Laboratories 27.3%
Tiny 27.3%
NutriPATH 22.7%
Microba1 22.7%
GanzimmunDiag 22.7%
DayTwo 18.2%
Metagenomics Stool (De Meirleir) (16s Limited) 18.2%
Microbiome Healthpath Maxi 13.6%
InVitaLab (cfu/gm) 13.6%
GI EcologiX (Invivo) 13.6%
GI360 Stool (UK) 13.6%
Bioscreen (cfu/gm) 13.6%
Biovis Microbiome Plus (cfu/g) 13.6%
Tarmkollen Mega 13.6%
Verisana (cfu/ml) aka (kbe/ml) 9.1%
GanzImmun Diagnostic A6 (cfu/gm) 9.1%
Genova Parasitology (cfu/g) 9.1%
Medivere Mikrobiom Plus Stuhlanalyse 9.1%
Medivere: Darn Magen Diagnostik (16s Limited) 9.1%
Medivere: Gesundsheitscheck Darm (16s Limited) 9.1%
Kyber Kompakt (cfu/g) 4.5%
GanzImmun Diagnostics AG Befundbericht 4.5%
Viome (Latest Reports Fail to provide ANY measurements) 4.5%

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.